Emerging Market R&D Flatters To Deceive

BMI View: Despite new research that shows that China and India are increasingly publishing the results of scientific experiments for international peer review, it is unlikely that either country will launch a new molecular entity (NME) within the next five years. If a Chindia-discovered pharmaceutical emerges before then it will need to be funded, and therefore owned by a foreign drugmaker.

To read the full article, please choose one of the following options: